Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study
Article by ImPrEP published at The Lancet Regional Health – Americas in July, 2026.
https://www.sciencedirect.com/science/article/pii/S2667193X26001523